Shire

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Contact Details

Address: 22 Grenville Street, St Helier, Jersey

Phone: +44 (0) 1256 894 000

Fax: +44 (0) 1256 894 708

Website: http://www.shire.com

Related news from City A.M.

UK bags Europe's M&A top spot with $247bn of deals in 2018 as TMT mergers grow
UK bags Europe's M&A top spot with $247bn of deals in 2018 as TMT mergers grow
The UK enjoyed the highest value of M&A deals in Europe last year as telecoms and media takeovers spiked. High [...]
February 19, 2019
Takeda finishes £46bn Shire takeover months ahead of schedule
Takeda finishes £46bn Shire takeover months ahead of schedule
Takeda has completed the takeover of London-listed Shire ahead of schedule after shareholders overwhelmingly backed the controversial $59bn (£46bn) deal [...]
January 8, 2019
Takeda wins shareholder approval for £46bn Shire takeover
Takeda’s investors have approved the company’s $59bn (£46bn) takeover of Irish drugmaker Shire following months of wrangling with unhappy stakeholders. [...]
December 5, 2018
Big pharma: Takeda sets date for shareholder vote on $62bn Shire merger
Big pharma: Takeda sets date for shareholder vote on $62bn Shire merger
Takeda Pharmaceutical will ask shareholders to vote on buying biotechnology firm Shire for $62bn (£48bn) on 5 December, it revealed [...]
November 12, 2018
Shire looks to lift $30bn bid for rival Baxalta
Shire looks to lift $30bn bid for rival Baxalta
Irish drug giant Shire Pharma­ceuticals is prepared to top up its offer to woo rival Baxalta to the negotiating table [...]
August 16, 2015
Baxalta hints it will accept a bid from Shire, but only if it offers an extra $5bn
Baxalta hints it will accept a bid from Shire, but only if it offers an extra $5bn
Shire's attempt to buy Baxalta could prove successful, so long as the pharmaceutical company agrees to add an extra $5bn [...]
August 16, 2015
Shire share price rises as investors become optimistic about Baxalta hostile takeover bid
Shire share price rises as investors become optimistic about Baxalta hostile takeover bid
Shares in pharma giant Shire recovered this morning after its $30bn (£19bn) hostile bid to take over US biotech company [...]
August 10, 2015
Shire share price drops following £19bn hostile takeover bid to Baxalta
Shire share price drops following £19bn hostile takeover bid to Baxalta
London-listed pharma giant Shire has made a hostile approach for US rival Baxalta. In a statement, the UK company offered $45.23 [...]
August 10, 2015
Shire ramps up bid to win over Baxalta board
Shire ramps up bid to win over Baxalta board
The board of Baxalta will come under renewed pressure to open takeover negotiations this week, following early campaigning by Shire [...]
August 10, 2015
Shire rebuffed over £12bn move for its listed Swiss rival Actelion
Shire rebuffed over £12bn move for its listed Swiss rival Actelion
ADHD drug-maker Shire is looking at a £12.4bn takeover of Europe’s biggest biotech company Actelion – just months after completing [...]
June 7, 2015
Shire given nod by US for binge-eating disorder drug Vyvanse
Shire given nod by US for binge-eating disorder drug Vyvanse
Drugs giant Shire traded up to three per cent higher yesterday morning and closed 0.95 per cent up, after news [...]
February 2, 2015
Shire’s NPS deal validated as US approves drugs
Shire’s NPS deal validated as US approves drugs
SHIRE’S $5.2bn (£3.45bn) takeover of NPS Pharmaceuticals just weeks ago is already paying off. Shire shares rose 1.08 per cent [...]
January 26, 2015
Shire splashes out AbbVie cash with $5.2bn acquisition of NPS Pharma
Shire splashes out AbbVie cash with $5.2bn acquisition of NPS Pharma
UK drugmaker Shire bounced back from its botched takeover by pharma giant AbbVie last night to seal a $5.2bn acquisition [...]
January 12, 2015
Shire to acquire NPS Pharma in $5.2bn merger
Shire to acquire NPS Pharma in $5.2bn merger
UK company Shire is to aquire with NPS Pharmaceuticals, according to a statement by the companies.The two have entered into [...]
January 11, 2015

Content tagged with "Shire"